PolTREG S.A. (PTG) - Total Liabilities
Based on the latest financial reports, PolTREG S.A. (PTG) has total liabilities worth zł30.71 Million PLN (≈ $8.45 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore PolTREG S.A. annual equity growth to track the company's year-over-year net asset growth rate.
PolTREG S.A. - Total Liabilities Trend (2018–2024)
This chart illustrates how PolTREG S.A.'s total liabilities have evolved over time, based on quarterly financial data. See cash generation quality of PolTREG S.A. to measure how efficiently the company converts operating cash flow to free cash.
PolTREG S.A. Competitors by Total Liabilities
The table below lists competitors of PolTREG S.A. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Beeline Holdings, Inc.
NASDAQ:BLNE
|
USA | $19.35 Million |
|
Pritika Auto Industries Limited
NSE:PRITIKAUTO
|
India | Rs2.69 Billion |
|
NATUZZI S.P.A. ADR/5 EO 1
F:NTZA
|
Germany | €248.90 Million |
|
Westport Fuel Systems Inc
TO:WPRT
|
Canada | CA$22.19 Million |
|
Osangjaiel Co. Ltd
KQ:053980
|
Korea | ₩50.20 Billion |
|
BOS Better Online Solutions
NASDAQ:BOSC
|
USA | $15.94 Million |
|
Gyeongnam Steel Co. Ltd
KQ:039240
|
Korea | ₩45.20 Billion |
|
Saranacentral Bajatama Tbk
JK:BAJA
|
Indonesia | Rp663.39 Billion |
Liability Composition Analysis (2018–2024)
This chart breaks down PolTREG S.A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of PolTREG S.A..
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.77 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.62 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.38 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how PolTREG S.A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for PolTREG S.A. (2018–2024)
The table below shows the annual total liabilities of PolTREG S.A. from 2018 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | zł33.15 Million ≈ $9.12 Million |
-16.26% |
| 2023-12-31 | zł39.58 Million ≈ $10.89 Million |
+77.77% |
| 2022-12-31 | zł22.27 Million ≈ $6.13 Million |
+263.93% |
| 2021-12-31 | zł6.12 Million ≈ $1.68 Million |
+79.41% |
| 2020-12-31 | zł3.41 Million ≈ $938.48K |
-50.23% |
| 2019-12-31 | zł6.85 Million ≈ $1.89 Million |
-29.37% |
| 2018-12-31 | zł9.70 Million ≈ $2.67 Million |
-- |
About PolTREG S.A.
Poltreg S.A., a biotechnology company, researches and develops therapies for autoimmune diseases. It engages in the development of therapies for the treatment of type 1 diabetes in children, as well as multiple sclerosis. The company was incorporated in 2016 and is based in Gdansk, Poland.